Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06GYY
|
|||
| Drug Name |
Ifenprodil
|
|||
| Synonyms |
Ifenprodil; 23210-56-2; ifenprodil tartrate; Vadilex; Dilvax; Creocral; Ifenprodil [INN:DCF]; RC 61-91; Ifenprodilum [INN-Latin]; UNII-R8OE3P6O5S; EINECS 245-491-4; R8OE3P6O5S; CHEMBL305187; IFENPRODIL HEMITARTRATE; NCGC00024643-03; Ifenprodil
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2/3 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H27NO2
|
|||
| Canonical SMILES |
CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
|
|||
| InChI |
1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3
|
|||
| InChIKey |
UYNVMODNBIQBMV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 23210-56-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:93829
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04382924) Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.